| Literature DB >> 34993836 |
Hazal Yakut1, Hüseyin Dursun2, Elvan Felekoğlu3, Ahmet Anıl Başkurt2, Aylin Özgen Alpaydın4, Sevgi Özalevli5.
Abstract
BACKGROUND: Supervised high-intensity interval training (HIIT) has been proposed to be more effective than moderate-intensity continuous training (MICT) for improving exercise capacity, but there are not sufficient information effects of home-based HIIT and MICT in patients with myocardial infarction (MI). AIMS: To compare the effects of home-based HIIT and MICT in patients with MI.Entities:
Keywords: Functional capacity; Health-related quality of life; High-intensity interval training; Home-based exercise; Myocardial infarction
Year: 2022 PMID: 34993836 PMCID: PMC8736320 DOI: 10.1007/s11845-021-02867-x
Source DB: PubMed Journal: Ir J Med Sci ISSN: 0021-1265 Impact factor: 2.089
Fig. 1Flow diagram of the study. MI myocardial infarction, HIIT high-intensity interval training, MICT moderate-intensity continuous training
Demographic and clinical parameters of groups before the intervention
| Gender, male/female (%) | 10(90)/1(10) | 8 (80)/2(20) | 0.566§ |
| Age (yrs) | 59.6 ± 4.5 | 58.5 ± 5.6 | 0.652* |
| Height (cm) | 168.8 ± 9.1 | 169.1 ± 5.7 | 0.934* |
| Weight (kg) | 82.1 ± 13.2 | 82.3 ± 16.7 | 0.979* |
| Month between EI and MI | 5.5 ± 0.6 | 5.0 ± 1.2 | 0.305* |
| Hypertension, | 6 (54) | 7 (70) | 0.474* |
| Diabetes mellitus, | 4 (36) | 6 (60) | 0.370* |
| Chronic pulmonary disease, | 3 (27) | 4 (40) | 0.642* |
| Charlson comorbidity index score | 3.0 (2.0, 3.0) | 3.0 (2.5, 5.0) | 0.311† |
| PCI, | 6 (54) | 8 (80) | 0.457* |
| CABG, | 3 (27) | 4 (40) | 0.642* |
| Smoker, | 5 (45) | 4 (40) | 0.850§ |
| Ex-smoker, | 4 (36) | 5 (50) | 0.850§ |
| Non-smoker, | 2 (19) | 1 (10) | 0.769§ |
| Cigarette consumption (pack-yrs) | 27.4 ± 14.7 | 29.2 ± 18.1 | 0.861 |
| Regular exercise, yes/no, | 4(36)/ 7(64) | 2 (20)/ 8(80) | 0.329§ |
Data are expressed as mean ± SD and median (interquartile range) or n (%), § chi-squared test or Fisher’s exact test,
HIIT high-intensity interval training, MICT moderate-intensity continuous training, MI myocardial infarction, EI exercise intervention, PCI percutaneous coronary intervention, CABG coronary artery bypass graft
*independent Student’s t-tests,
† Mann–Whitney U tests,
High-intensity interval training group versus moderate-intensity continuous training group: baseline outcome variables
| Variables | HIIT | MICT | |
|---|---|---|---|
| Functional capacity | |||
| 509.0 ± 59.8 | 491.8 ± 79.7 | 0.654* | |
| Resting blood pressure and heart rate | |||
| 141.6 ± 10.1 | 145.5 ± 12.6 | 0.363* | |
| 79.1 ± 12.2 | 85.0 ± 9.3 | 0.248* | |
| 77.1 ± 13.6 | 85.3 ± 18.7 | 0.269* | |
| Peripheral oxygen saturation | |||
| 95.1 ± 2.1 | 95.1 ± 0.8 | 0.978 | |
| Pulmonary function | |||
| 82.9 ± 9.2 | 77.0 ± 16.7 | 0.330* | |
| 83.4 ± 7.8 | 79.8 ± 10.8 | 0.388* | |
| 79.1 ± 5.1 | 74.3 ± 11.3 | 0.228* | |
| 69.3 ± 16.2 | 69.7 ± 16.1 | 0.945* | |
| Respiratory muscle strength | |||
| 92.4 ± 12.7 | 91.3 ± 16.0 | 0.892* | |
| 63.5 ± 12.8 | 64.3 ± 12.5 | 0.842* | |
| Dyspnea severity | |||
| 0.5 (0.0, 1.0) | 1.0 (0.5, 2.0) | 0.201† | |
| Body composition | |||
| 29.3 ± 5.2 | 29.4 ± 5.3 | 0.965* | |
| 29.1 ± 9.6 | 29.8 ± 7.3 | 0.883* | |
| 57.4 ± 7.7 | 57.68 ± 9.1 | 950* | |
| Peripheral muscle strength | |||
| 10.5 ± 2.7 | 9.3 ± 2.5 | 0.850* | |
| 36.9 ± 7.4 | 33.9 ± 10.0 | 0.456* | |
| Health-related quality of life | |||
| 5.5 ± 1.0 | 5.6 ± 1.2 | 0.706* | |
| 5.6 ± 0.9 | 5.5 ± 1.1 | 0.307* | |
| 5.7 ± 1.1 | 5.2 ± 1.0 | 0.619* | |
| 5.5 ± 0.6 | 5.5 ± 1.1 | 0.267* |
Data are expressed as mean ± SD and median (interquartile range),
HIIT high-intensity interval training, MICT moderate-intensity continuous training, 6MWT 6-min walk test, BP blood pressure, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, PEF peak expiratory flow, MIP maximal inspiratory pressure, MEP maximal expiratory pressure, mMRC Modified Medical Research Council, BMI body mass index, FFM fat free muscle, KES knee extensor strength, HGS handgrip strength, HRQoL health-related quality of life
* independent Student’s t-tests,
† Mann–Whitney U tests,
Comparison of changes in clinical parameters of groups after the intervention
| Variables | |||||||
|---|---|---|---|---|---|---|---|
| Before | After | Before | After | ||||
| 6MWT (m) | 509.0 ± 59.8 | 549.4 ± 62.3 | 491.9 ± 79.7 | 517.4 ± 82.1 | |||
| ∆ 6MWT (m) | 40.3 ± 34.4 | 25.5 ± 20.7 | 0.386* | ||||
| SBP (mmHg) | 141.6 ± 10.1 | 129.0 ± 9.8 | 145.5 ± 12.6 | 135.1 ± 16.1 | |||
| ∆SBP(mmHg) | − 11.6 ± 9.4 | − 10.4 ± 9.5 | 0.782* | ||||
| DBP (mmHg) | 79.1 ± 12.2 | 73.8 ± 11.2 | 85.0 ± 9.3 | 77.6 ± 6.9 | |||
| ∆DBP(mmHg) | − 5.3 ± 4.9 | − 7.4 ± 6.2 | 0.435* | ||||
| HR(beats/min) | 77.1 ± 13.6 | 68.2 ± 10.2 | 85.3 ± 9.3 | 74.9 ± 10.9 | |||
| ∆HR(beats/min) | − 8.9 ± 7.1 | − 10.4 ± 10.3 | 0.731* | ||||
| SpO2, % | 95.1 ± 2.1 | 96.1 ± 2.1 | 95.1 ± 0.8 | 96.3 ± 1.1 | |||
| ∆SpO2, % | 1.0 ± 1.0 | 1.2 ± 1.2 | 0.671* | ||||
| FEV1, %pred | 82.9 ± 9.2 | 87.0 ± 7.5 | 77.0 ± 16.8 | 78.3 ± 17.3 | |||
| ∆ FEV1, %pred | 4.1 ± 1.6 | 1.3 ± 1.1 | |||||
| FVC, %pred | 83.4 ± 7.8 | 87.5 ± 7.8 | 79.8 ± 10.8 | 81.2 ± 9.6 | |||
| ∆ FVC, %pred | 4.1 ± 1.6 | 1.4 ± 1.2 | |||||
| FEV1/FVC, % | 79.1 ± 5.1 | 82.4 ± 5.8 | 74.3 ± 11.3 | 76.9 ± 9.8 | |||
| ∆FEV1/FVC, % | 3.3 ± 1.6 | 2.5 ± 1.8 | 0.379* | ||||
| PEF, %pred | 69.3 ± 16.2 | 73.4 ± 15.2 | 69.8 ± 16.1 | 70.7 ± 16.6 | |||
| ∆ PEF, %pred | 4.2 ± 3.6 | 0.9 ± 0.7 | |||||
| MIP, %pred | 92.4 ± 12.7 | 107.7 ± 20.1 | 91.3 ± 16.0 | 92.5 ± 15.4 | 0.249 | ||
| ∆ MIP, %pred | 15.4 ± 13.7 | 1.9 ± 1.2 | 0.110* | ||||
| MEP, %pred | 63.5 ± 12.8 | 78.4 ± 13.4 | 64.3 ± 12.5 | 80.1 ± 25.1 | |||
| ∆ MEP, %pred | 14.9 ± 9.9 | 16.0 ± 11.1 | 0.835* | ||||
| mMRC score | 0.5 (0.0, 1.0) | 0.0 (0.0, 0.0) | 1.0 (0.5, 2.0) | 1.0 (0.0, 1.5) | 0.157** | ||
| ∆ mMRC score | 0.0 (− 1.0, 0.0) | 0.0 (− 0.5, 0.0) | 0.552† | ||||
Data are expressed as mean ± SD and median (interquartile range),
HIIT high-intensity interval training, MICT moderate-intensity continuous training, ∆ after-before difference, 6MWT 6-min walk test, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, SpO peripheral oxygen saturation, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, PEF peak expiratory flow, MIP maximal inspiratory pressure, MEP maximal expiratory pressure, mMRC Modified Medical Research Council
* independent Student’s t-tests,
Wilcoxon test,
† Mann–Whitney U tests, paired Student t tests,
Comparison of changes in clinical parameters of groups after the intervention
| Variables | |||||||
|---|---|---|---|---|---|---|---|
| Before | After | Before | After | ||||
| BMI, (kg/m2 | 29.3 ± 5.2 | 28.1 ± 5.1 | 29.4 ± 5.3 | 28.3 ± 4.9 | |||
| ∆ BMI, (kg/m2) | -1.2 ± 0.8 | -1.1 ± 0.9 | 0.776* | ||||
| Body fat % | 29.1 ± 9.6 | 26.3 ± 10.3 | 29.8 ± 7.3 | 27.5 ± 7.9 | |||
| ∆ Body fat % | -2.7 ± 2.6 | -1.6 ± 1.8 | 0.287* | ||||
| FFM (kg) | 57.4 ± 7.7 | 58.5 ± 7.9 | 0.214§ | 57.7 ± 9.1 | 59.1 ± 9.8 | 0.321§ | |
| ∆ FFM (kg) | 1.1 ± 1.7 | 1.4 ± 1.6 | 0.800* | ||||
| KES (kg) | 10.5 ± 2.7 | 14.9 ± 3.1 | 9.3 ± 2.5 | 10.3 ± 2.5 | |||
| ∆ KES (kg) | 4.4 ± 2.1 | 1.0 ± 0.6 | |||||
| HGS (kg) | 36.9 ± 7.4 | 40.6 ± 7.8 | 33.9 ± 10.0 | 35.8 ± 8.8 | |||
| ∆ HGS (kg) | 3.7 ± 2.7 | 1.9 ± 1.4 | 0.070* | ||||
| MacNew HRQoL | |||||||
| 5.5 ± 1.0 | 6.0 ± 0.5 | 5.3 ± 1.0 | 5.6 ± 1.2 | 0.241§ | |||
| 0.5 ± 0.3 | 0.3 ± 0.1 | 0.362* | |||||
| 5.7 ± 0.9 | 6.1 ± 0.7 | 5.1 ± 1.5 | 5.5 ± 1.1 | 0.062 | |||
| 0.4 ± 0.2 | 0.4 ± 0.2 | 0.862* | |||||
| 5.7 ± 1.1 | 5.8 ± 0.9 | 5.41 ± 1.43 | 5.2 ± 1.0 | 0.677 | |||
| 0.1 ± 0.3 | 0.1 ± 0.0 | 0.632* | |||||
| 5.5 ± 0.6 | 5.8 ± 0.5 | 5.04 ± 1.16 | 5.5 ± 1.1 | ||||
| 0.3 ± 0.3 | 0.4 ± 0.2 | 0.660* | |||||
Data are expressed as mean ± SD and median (interquartile range),
HIIT high-intensity interval training, MICT moderate-intensity continuous training, ∆ after-before difference, BMI body mass index, FFM fat free muscle, KES knee extensor strength, HGS handgrip strength, HRQoL health-related quality of life
* independent Student’s t-tests,
Wilcoxon test,
† Mann–Whitney U tests, paired Student t tests,